Skip to main content
. 2016 Sep 23;82(6):1591–1600. doi: 10.1111/bcp.13092

Figure 3.

Figure 3

Mean plasma concentrations of (A) edoxaban (B) and metabolite M4 following administration with and without erythromycin. Insets represent the first 24 h postdose; error bars represent the standard deviation